Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wa'ed Ventures is the venture capital arm of Saudi Aramco, established in 2011 to promote economic diversification and entrepreneurship within the Kingdom of Saudi Arabia. The firm manages a $500 million fund, investing in high-potential startups across various sectors, including healthcare, biotechnology, fintech, and sustainability. Wa'ed provides a comprehensive support system for entrepreneurs, offering equity investment, incubation programs, and debt financing. In the life sciences space, the firm focuses on digital health, medical devices, and innovative biotech solutions that align with the goals of Saudi Vision 2030. By bridging the gap between local innovation and global venture capital, Wa'ed Ventures plays a pivotal role in developing the Saudi Arabian startup ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wa'ed Ventures.